Cognitive-behavioural group therapy for severe functional somatic syndromes -treatment model and empirical evidence;Kognitiv-behaviorale Gruppentherapie für Funktionelle Syndrome - Behandlungsmodell und Wirksamkeitsnachweis

Verhaltenstherapie und Verhaltensmedizin

Volumn 35, Issue 1, 2014, Pages 3-23

  Schröder, Andreas ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cognitive behavioural therapy; Evidence based medicine; Functional somatic syndromes; Illness model; Somatoform disorders

Indexed keywords

EID: 84896911725     PISSN: 10131973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Barsky, A. J., Orav, E. J. & Bates, D. W. (2005). Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry, 62, 903-910. (Pubitemid 41126885)
2. Bradley, L. A. (2008). Pathophysiologic mechanisms of fibromyalgia and its related disorders. Journal of Clinical Psychiatry, 69, 6-13.
3. Burgmer, M., Gaubitz, M., Konrad, C. et al. (2009). Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosomatic Medicine, 71, 566-573.
4. Burton, C. (2003). Beyond somatisation: A review of the understanding and treatment of medically unexplained physical symptoms (MUPS). British Journal of General Practice, 53, 231-239.
5. Chang, L. (2005). Brain responses to visceral and somatic stimuli in irritable bowel syndrome: A central nervous system disorder? Gastroenterology Clinics of North America, 34, 271-279.
6. Clauw, D. J. (2001). Potential mechanisms in chemical intolerance and related conditions. Annals of the New York Academy of Sciences, 933, 235-253.
7. Creed, F., Henningsen, P. & Fink, P. (2011). Medically unexplained symptoms, somatisation and bodily distress. Developing better clinical services. Cambridge: Cambridge University Press.
8. Creed, F., van der Feltz-Cornelis, C, Guthrie, E. et al. (2011). Identification, assessment and treatment of individual patients. In:F. Creed, P. Henningsen & P. Fink (Hrsg.), Medically unexplained symptoms, somatisation and bodily distress. Developing better clinical services (S. 175-216). Cambridge: Cambridge University Press.
9. de Lange, F. P., Koers, A., Kalkman, et al. (2008). Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain, 131, 2172-2180.
10. Deary, V., Chalder, T. & Sharpe, M. (2007). The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical review. Clinical Psychology Review, 27, 781-797. (Pubitemid 47422313)
11. Fink, P., Burton, C, de Bie, J. et al. (2011). Current state of management and organisation of care. In: F. Creed, P. Henningsen & P. Fink (Hrsg.), Medically unexplained symptoms, somatisation and bodily distress: Developing better clinical services (S. 97-123). Cambridge: Cambridge University Press.
12. Fink, P. & Schröder, A. (2010). One single diagnosis, bodily distress syndrome, succeeded to capture ten diagnostic categories of functional somatic syndromes and somatoform disorders. Journal of Psychosomatic Research, 68, 415-426.
13. Fink, P., Toft, T, Hansen, M. S. et al. (2007). Symptoms and syndromes of bodily distress: An exploratory study of 978 internal medical, neurological, and primary care patients. Psychosomatic Medicine, 69, 30-39. (Pubitemid 46148362)
14. Fritzsche, K. (2011). Bedarf und Inanspruchnahme psychosomatischer Konsil- und Liaisonleistungen. Verhaltenstherapie und Verhaltensmedizin, 32, 51-68.
15. Frostholm, L., Oernboel, E., Christensen, K. S. et al. (2007). Do illness perceptions prediet health outcomes in primary care patients? A 2-year follow-up study. Journal of Psychosomatic Research, 62,129-138. (Pubitemid 46161586)
16. Glombiewski, J. A., Rief, W., Bosner, S. et al. (2010). The course of nonspecific chest pain in primary care: Symptom persistence and health care usage. Archives of Internal Medicine, 170, 251-255.
17. Glombiewski, J. A., Sawyer, A. T., Gutermann, J. et al. (2010). Psychological treatments for fibromyalgia: A meta-analysis. Pain, 151, 280-295.
18. Gottschalk, J. M. & Rief, W. (2012). Psychotherapeutische Ansätze für Patienten mit somatoformen Störungen. Nervenarzt, 83, 1115-1127.
19. Gundel, H., Valet, M., Sorg, C. et al. (2008). Altered cerebral response to noxious heat Stimulation in patients with somatoform pain disorder. Pain, 137, 413-421.
20. Henningsen, P., Zipfel, S. & Herzog, W. (2007) . Management of functional somatic syndromes. Lancet, 369, 946-955.
21. Holm, L. W., Carroll, L. J., Cassidy, J. D. et al. (2008) . Expectations for recovery important in the prognosis of whiplash injuries. PLoS Medicine, 5, e105.
22. Kisely, S. R., Campbell, L. A., Skerritt, P. & Yelland, M. J. (2010). Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD004101. doi:10.1002/14651858. CD004101.pub3.
23. Kleinstäuber, M., Witthöft, M. & Hiller, W. (2011) . Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: A meta-analysis. Clinical Psychology Review, 31, 146-160.
24. Knoop, H., Prins, J. B., Moss-Morris, R. & Bleijenberg, G. (2010). The central role of cognitive processes in the perpetuation of chronic fatigue syndrome. Journal of Psychosomatic Research, 68, 489-494.
25. Knoop, H., van Kessel, K. K. & Moss-Morris, R. (2012) . Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis? Psychological Medicine, 42, 205-213.
26. Kroenke, K. (2007). Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosomatic Medicine, 69, 881-888.
27. Lahmann, C, Henningsen, P. & Dinkel, A. (2010). Somatoforme Störungen und funktionelle Störungen. Nervenarzt, 81, 13831394.
28. Levenson, J. L. (2011). The somatoform disorders: 6 characters in search of an author. Psychiatric Clinics of North America, 34, 515-524.
29. Petrie, K. J., Cameron, L. D., Ellis, C. J. et al. (2002). Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosomatic Medicine, 64, 580-586. (Pubitemid 34791160)
30. Petrie, K. J., Jago, L. A. & Devcich, D. A. (2007). The role of illness perceptions in patients with medical conditions. Current Opinion in Psychiatry, 20, 163-167. (Pubitemid 46215425)
31. Petrie, K. J., Weinman, J., Sharpe, N. & Buckley, J. (1996). Role of patients' view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. British Medical Journal, 312, 1191-1194. (Pubitemid 26136704)
32. Rief, W. & Barsky, A. J. (2005). Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology, 30, 996- 1002.
33. Rief, W. & Broadbent, E. (2007). Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review, 27, 821-841. (Pubitemid 47410330)
34. Schaefert, R., Hausteiner-Wiehle, C., Hauser, W. et al. (2012). Non-specific, functional, and somatoform bodily complaints. Deutsches Ärzteblatt International, 109, 803-813.
35. Schröder, A. & Fink, P. (2011). Functional somatic syndromes and somatoform disorders in special psychosomatic units: Organizational aspects and evidence-based treatment. Psychiatric Clinics of North America, 34, 673-687.
36. Schröder, A., Oernboel, E., Licht, R. W. et al. (2012). Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid. Journal of Clinical Epidemiology, 65, 30-41.
37. Schröder, A., Rehfeld, E., Oernboel, E. et al. (2012). Cognitive-behavioural group treatment for a range of functional somatic syndromes: Randomised trial. British Journal of Psychiatry, 200, 499-507.
38. Schweinhardt, P., Saura, K. M. & Bushneil, M. C. (2008). Fibromyalgia: A Disorder of the Brain? Neuroscientist, 14, 415-421.
39. Sharpe, M. & Carson, A. (2001). "Unexplained" somatic symptoms, functional syndromes, and somatization: Do we need a paradigm shift? Annals of Internal Medicine, 134, 926-930. (Pubitemid 32405702)
40. Shattock, L., Williamson, H., Caldwell, K. et al. (2013). 'They've just got symptoms without science': Medical trainees' acquisition of negative attitudes towards patients with medically unexplained symptoms. Patient Education and Counseling, 91, 249-254.
41. Song, G. H., Venkatraman, V., Ho, K. V. et al. (2006). Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain, 126, 79-90. (Pubitemid 44751957)
42. Sumathipala, A. (2007). What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosomatic Medicine, 69, 889-900.
43. Toft, T., Fink, P., Oernboel, E. et al. (2005). Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the functional illness in primary care (FIP) study. Psychological Medicine, 35, 1175-1184. (Pubitemid 41103009)
44. Valet, M., Gundel, H., Sprenger, T. et al. (2009). Patients with pain disorder show gray-matter loss in pain-processing structures: a voxel-based morphometric study. Psychosomatic Medicine, 71, 49-56.
45. Ware, J., Kosinski, M. & Gandek, B. (2005). SF-36 Health Survey: Manual & Interpretation Guide. Lincoln, Rl: Quality Metric Incorporated.
46. White, P. D., Goldsmith, K. A., Johnson, A. L. et al. (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial. Lancet., 377, 823-836.
47. Wittchen, H. U. & Jacobi, F. (2005). Size and burden of mental disorders in Europe - A critical review and appraisal of 27 studies. European Neuropsychopharmacology, 15, 357-376.
48. Wood, P. B. (2005). Neuroimaging in functional somatic syndromes. International Review of Neurobiology, 67, 119-163.
49. Yunus, M. B. (2008). Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Seminars in Arthritis and Rheumatism, 37, 339-352.